Free Trial
→ The REAL Reason Trump is Invading Iran (From Banyan Hill Publishing) (Ad)tc pixel Free LFST Stock Alerts

LifeStance Health Group (LFST) Competitors

LifeStance Health Group logo
$7.64 +0.14 (+1.87%)
Closing price 06/4/2026 04:00 PM Eastern
Extended Trading
$7.74 +0.10 (+1.24%)
As of 06:10 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

LFST vs. BTSG, CELC, PACS, HIMS, and SHC

Should you buy LifeStance Health Group stock or one of its competitors? MarketBeat compares LifeStance Health Group with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with LifeStance Health Group include BrightSpring Health Services (BTSG), Celcuity (CELC), PACS Group (PACS), Hims & Hers Health (HIMS), and Sotera Health (SHC). These companies are all part of the "healthcare" industry.

How does LifeStance Health Group compare to BrightSpring Health Services?

LifeStance Health Group (NASDAQ:LFST) and BrightSpring Health Services (NASDAQ:BTSG) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, risk, profitability, institutional ownership, media sentiment, valuation, earnings and analyst recommendations.

85.5% of LifeStance Health Group shares are owned by institutional investors. 3.2% of LifeStance Health Group shares are owned by company insiders. Comparatively, 2.8% of BrightSpring Health Services shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

BrightSpring Health Services has higher revenue and earnings than LifeStance Health Group. BrightSpring Health Services is trading at a lower price-to-earnings ratio than LifeStance Health Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
LifeStance Health Group$1.42B2.08$9.66M$0.06127.33
BrightSpring Health Services$12.91B0.86$190.67M$1.4140.71

LifeStance Health Group presently has a consensus price target of $9.86, indicating a potential upside of 29.02%. BrightSpring Health Services has a consensus price target of $57.64, indicating a potential upside of 0.42%. Given LifeStance Health Group's higher possible upside, equities research analysts plainly believe LifeStance Health Group is more favorable than BrightSpring Health Services.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
LifeStance Health Group
0 Sell rating(s)
2 Hold rating(s)
6 Buy rating(s)
2 Strong Buy rating(s)
3.00
BrightSpring Health Services
0 Sell rating(s)
0 Hold rating(s)
15 Buy rating(s)
2 Strong Buy rating(s)
3.12

In the previous week, BrightSpring Health Services had 1 more articles in the media than LifeStance Health Group. MarketBeat recorded 5 mentions for BrightSpring Health Services and 4 mentions for LifeStance Health Group. BrightSpring Health Services' average media sentiment score of 1.15 beat LifeStance Health Group's score of 0.96 indicating that BrightSpring Health Services is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
LifeStance Health Group
1 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
BrightSpring Health Services
2 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

BrightSpring Health Services has a net margin of 2.27% compared to LifeStance Health Group's net margin of 1.55%. BrightSpring Health Services' return on equity of 14.63% beat LifeStance Health Group's return on equity.

Company Net Margins Return on Equity Return on Assets
LifeStance Health Group1.55% 1.56% 1.07%
BrightSpring Health Services 2.27%14.63%4.41%

LifeStance Health Group has a beta of 1.19, meaning that its share price is 19% more volatile than the broader market. Comparatively, BrightSpring Health Services has a beta of 1.87, meaning that its share price is 87% more volatile than the broader market.

Summary

BrightSpring Health Services beats LifeStance Health Group on 11 of the 16 factors compared between the two stocks.

How does LifeStance Health Group compare to Celcuity?

LifeStance Health Group (NASDAQ:LFST) and Celcuity (NASDAQ:CELC) are both mid-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, risk, dividends, valuation, media sentiment, analyst recommendations, earnings and institutional ownership.

LifeStance Health Group has higher revenue and earnings than Celcuity. Celcuity is trading at a lower price-to-earnings ratio than LifeStance Health Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
LifeStance Health Group$1.42B2.08$9.66M$0.06127.33
CelcuityN/AN/A-$177.04M-$3.90N/A

LifeStance Health Group has a beta of 1.19, indicating that its share price is 19% more volatile than the broader market. Comparatively, Celcuity has a beta of 0.1, indicating that its share price is 90% less volatile than the broader market.

85.5% of LifeStance Health Group shares are held by institutional investors. Comparatively, 63.3% of Celcuity shares are held by institutional investors. 3.2% of LifeStance Health Group shares are held by insiders. Comparatively, 13.3% of Celcuity shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

LifeStance Health Group presently has a consensus price target of $9.86, suggesting a potential upside of 29.02%. Celcuity has a consensus price target of $152.09, suggesting a potential upside of 64.48%. Given Celcuity's higher probable upside, analysts plainly believe Celcuity is more favorable than LifeStance Health Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
LifeStance Health Group
0 Sell rating(s)
2 Hold rating(s)
6 Buy rating(s)
2 Strong Buy rating(s)
3.00
Celcuity
1 Sell rating(s)
0 Hold rating(s)
11 Buy rating(s)
0 Strong Buy rating(s)
2.83

In the previous week, Celcuity had 22 more articles in the media than LifeStance Health Group. MarketBeat recorded 26 mentions for Celcuity and 4 mentions for LifeStance Health Group. LifeStance Health Group's average media sentiment score of 0.96 beat Celcuity's score of 0.22 indicating that LifeStance Health Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
LifeStance Health Group
1 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Celcuity
4 Very Positive mention(s)
3 Positive mention(s)
7 Neutral mention(s)
1 Negative mention(s)
6 Very Negative mention(s)
Neutral

LifeStance Health Group has a net margin of 1.55% compared to Celcuity's net margin of 0.00%. LifeStance Health Group's return on equity of 1.56% beat Celcuity's return on equity.

Company Net Margins Return on Equity Return on Assets
LifeStance Health Group1.55% 1.56% 1.07%
Celcuity N/A -244.61%-50.22%

Summary

LifeStance Health Group beats Celcuity on 12 of the 16 factors compared between the two stocks.

How does LifeStance Health Group compare to PACS Group?

LifeStance Health Group (NASDAQ:LFST) and PACS Group (NYSE:PACS) are both mid-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, media sentiment, risk, dividends, profitability, analyst recommendations, institutional ownership and valuation.

85.5% of LifeStance Health Group shares are owned by institutional investors. 3.2% of LifeStance Health Group shares are owned by company insiders. Comparatively, 70.1% of PACS Group shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

In the previous week, LifeStance Health Group had 3 more articles in the media than PACS Group. MarketBeat recorded 4 mentions for LifeStance Health Group and 1 mentions for PACS Group. LifeStance Health Group's average media sentiment score of 0.96 beat PACS Group's score of 0.00 indicating that LifeStance Health Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
LifeStance Health Group
1 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
PACS Group
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

PACS Group has a net margin of 4.49% compared to LifeStance Health Group's net margin of 1.55%. PACS Group's return on equity of 26.47% beat LifeStance Health Group's return on equity.

Company Net Margins Return on Equity Return on Assets
LifeStance Health Group1.55% 1.56% 1.07%
PACS Group 4.49%26.47%4.36%

LifeStance Health Group currently has a consensus target price of $9.86, indicating a potential upside of 29.02%. PACS Group has a consensus target price of $48.00, indicating a potential upside of 28.05%. Given LifeStance Health Group's stronger consensus rating and higher probable upside, research analysts clearly believe LifeStance Health Group is more favorable than PACS Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
LifeStance Health Group
0 Sell rating(s)
2 Hold rating(s)
6 Buy rating(s)
2 Strong Buy rating(s)
3.00
PACS Group
0 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.71

PACS Group has higher revenue and earnings than LifeStance Health Group. PACS Group is trading at a lower price-to-earnings ratio than LifeStance Health Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
LifeStance Health Group$1.42B2.08$9.66M$0.06127.33
PACS Group$5.43B1.09$191.54M$1.5624.03

Summary

LifeStance Health Group beats PACS Group on 9 of the 16 factors compared between the two stocks.

How does LifeStance Health Group compare to Hims & Hers Health?

LifeStance Health Group (NASDAQ:LFST) and Hims & Hers Health (NYSE:HIMS) are both mid-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, risk, profitability, analyst recommendations, institutional ownership and media sentiment.

LifeStance Health Group has a beta of 1.19, indicating that its share price is 19% more volatile than the broader market. Comparatively, Hims & Hers Health has a beta of 2.37, indicating that its share price is 137% more volatile than the broader market.

LifeStance Health Group currently has a consensus price target of $9.86, indicating a potential upside of 29.02%. Hims & Hers Health has a consensus price target of $28.70, indicating a potential upside of 2.21%. Given LifeStance Health Group's stronger consensus rating and higher possible upside, analysts plainly believe LifeStance Health Group is more favorable than Hims & Hers Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
LifeStance Health Group
0 Sell rating(s)
2 Hold rating(s)
6 Buy rating(s)
2 Strong Buy rating(s)
3.00
Hims & Hers Health
2 Sell rating(s)
11 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.12

85.5% of LifeStance Health Group shares are owned by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are owned by institutional investors. 3.2% of LifeStance Health Group shares are owned by company insiders. Comparatively, 11.8% of Hims & Hers Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Hims & Hers Health had 17 more articles in the media than LifeStance Health Group. MarketBeat recorded 21 mentions for Hims & Hers Health and 4 mentions for LifeStance Health Group. LifeStance Health Group's average media sentiment score of 0.96 beat Hims & Hers Health's score of 0.84 indicating that LifeStance Health Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
LifeStance Health Group
1 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Hims & Hers Health
7 Very Positive mention(s)
7 Positive mention(s)
7 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Hims & Hers Health has higher revenue and earnings than LifeStance Health Group. Hims & Hers Health is trading at a lower price-to-earnings ratio than LifeStance Health Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
LifeStance Health Group$1.42B2.08$9.66M$0.06127.33
Hims & Hers Health$2.35B2.77$128.37M-$0.09N/A

LifeStance Health Group has a net margin of 1.55% compared to Hims & Hers Health's net margin of -0.56%. Hims & Hers Health's return on equity of 6.10% beat LifeStance Health Group's return on equity.

Company Net Margins Return on Equity Return on Assets
LifeStance Health Group1.55% 1.56% 1.07%
Hims & Hers Health -0.56%6.10%1.52%

Summary

LifeStance Health Group beats Hims & Hers Health on 9 of the 17 factors compared between the two stocks.

How does LifeStance Health Group compare to Sotera Health?

Sotera Health (NASDAQ:SHC) and LifeStance Health Group (NASDAQ:LFST) are both mid-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, media sentiment, risk, valuation, profitability, analyst recommendations, institutional ownership and dividends.

Sotera Health has higher earnings, but lower revenue than LifeStance Health Group. Sotera Health is trading at a lower price-to-earnings ratio than LifeStance Health Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sotera Health$1.16B3.82$77.94M$0.4137.98
LifeStance Health Group$1.42B2.08$9.66M$0.06127.33

Sotera Health presently has a consensus target price of $20.29, indicating a potential upside of 30.29%. LifeStance Health Group has a consensus target price of $9.86, indicating a potential upside of 29.02%. Given Sotera Health's higher probable upside, analysts clearly believe Sotera Health is more favorable than LifeStance Health Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sotera Health
0 Sell rating(s)
3 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.73
LifeStance Health Group
0 Sell rating(s)
2 Hold rating(s)
6 Buy rating(s)
2 Strong Buy rating(s)
3.00

Sotera Health has a beta of 1.79, indicating that its stock price is 79% more volatile than the broader market. Comparatively, LifeStance Health Group has a beta of 1.19, indicating that its stock price is 19% more volatile than the broader market.

91.0% of Sotera Health shares are owned by institutional investors. Comparatively, 85.5% of LifeStance Health Group shares are owned by institutional investors. 15.4% of Sotera Health shares are owned by insiders. Comparatively, 3.2% of LifeStance Health Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

In the previous week, LifeStance Health Group had 3 more articles in the media than Sotera Health. MarketBeat recorded 4 mentions for LifeStance Health Group and 1 mentions for Sotera Health. LifeStance Health Group's average media sentiment score of 0.96 beat Sotera Health's score of 0.94 indicating that LifeStance Health Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Sotera Health
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
LifeStance Health Group
1 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Sotera Health has a net margin of 9.91% compared to LifeStance Health Group's net margin of 1.55%. Sotera Health's return on equity of 39.73% beat LifeStance Health Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Sotera Health9.91% 39.73% 7.05%
LifeStance Health Group 1.55%1.56%1.07%

Summary

Sotera Health beats LifeStance Health Group on 11 of the 17 factors compared between the two stocks.

Get LifeStance Health Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for LFST and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding LFST and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LFST vs. The Competition

Export
MetricLifeStance Health GroupMED IndustryMedical SectorNASDAQ Exchange
Market Cap$2.91B$5.52B$6.30B$12.43B
Dividend YieldN/A1.59%2.69%5.32%
P/E Ratio127.3333.0923.7324.34
Price / Sales2.0825.18496.6895.47
Price / Cash44.5915.7241.3955.53
Price / Book1.953.0810.046.72
Net Income$9.66M$218.81M$3.56B$337.03M
7 Day Performance-0.91%-1.66%-1.01%-0.16%
1 Month Performance3.87%-0.63%2.21%3.74%
1 Year Performance28.84%9.80%28.96%34.34%

LifeStance Health Group Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LFST
LifeStance Health Group
4.3951 of 5 stars		$7.64
+1.9%		$9.86
+29.0%		+28.4%$2.91B$1.42B127.3310,961
BTSG
BrightSpring Health Services
4.1829 of 5 stars		$60.32
+3.1%		$57.00
-5.5%		+143.4%$11.70B$12.91B42.7823,500
CELC
Celcuity
3.2179 of 5 stars		$134.26
-2.9%		$149.30
+11.2%		+671.9%$6.55BN/AN/A40
PACS
PACS Group
4.027 of 5 stars		$38.87
+3.0%		$48.00
+23.5%		+268.9%$6.15B$5.29B24.9247,455
HIMS
Hims & Hers Health
2.5958 of 5 stars		$23.79
+0.2%		$28.70
+20.6%		-47.8%$5.42B$2.35BN/A2,442

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:LFST) was last updated on 6/5/2026 by MarketBeat.com Staff.
From Our Partners
The 1934 playbook
In 1934, a legal government maneuver transferred billions in wealth overnight. Most Americans never saw it com...
American Alternative | Sponsoredtc pixel
$30 stock to buy before Starlink goes public (WATCH NOW!)
In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...
Paradigm Press | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
June 12: $100 Turns Into $100,000?
The SpaceX IPO is scheduled for June 12, and former tech executive Jeff Brown - who identified Bitcoin, Tesla,...
Brownstone Research | Sponsoredtc pixel
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel
SpaceX just filed. The clock is ticking.
Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...
The Oxford Club | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
SpaceX will mint billionaires. You won't be one of them.
By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...
Behind the Markets | Sponsoredtc pixel